Actinium presents data on Actimab-A mechanism at cancer research meeting
Go back to Actinium presents data on Actimab-A mechanism at cancer research meeting| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $3.50 | |||
| Open | $1.03 | 52 Week Low | $0.86 | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $-7.61 | |||
| Volume | 2,509 | |||||
